Skip to main content

Advertisement

Log in

Highlights of the 2011 Scientific Session of the American Society of Nuclear Cardiology

Denver, Colorado, September 8-11, 2011

  • Abstracts/Proceedings
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Disclosures

Raymond Russell: none; Brian Abbott: advisory board member for Astellas Pharma; James Arrighi: speaker’s bureau and advisory board for Astellas Pharma; Ron Blankstein: none; Tracy Faber: grant support from GE Healthcare, royalties from the Emory Cardiac Toolbox, and has an equity position in Syntermed, Inc.; John Mahmarian: consultant and speaker’s bureau for Astellas Pharma, consultant for GE Healthcare; Edward Miller: none; Todd Miller: consultant for Astellas Pharma and Lantheus Medical Imaging; Leslee Shaw: grant support from Astellas Pharma and Bracco Diagnostics; Prem Soman: consultant for GE Healthcare and Astellas Pharma; Mark Travin: advisory board member for GE Healthcare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raymond R. Russell MD, PhD, FASNC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, R.R., Abbott, B.G., Arrighi, J.A. et al. Highlights of the 2011 Scientific Session of the American Society of Nuclear Cardiology. J. Nucl. Cardiol. 19, 158–164 (2012). https://doi.org/10.1007/s12350-011-9479-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-011-9479-4

Keywords

Navigation